Compare FSI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSI | ZTEK |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 89.3M |
| IPO Year | 1999 | N/A |
| Metric | FSI | ZTEK |
|---|---|---|
| Price | $6.86 | $0.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 56.4K | 45.0K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $38,563,427.00 | $657,134.00 |
| Revenue This Year | $8.45 | N/A |
| Revenue Next Year | $51.24 | N/A |
| P/E Ratio | $49.13 | ★ N/A |
| Revenue Growth | 0.18 | ★ 2225.73 |
| 52 Week Low | $3.46 | $0.62 |
| 52 Week High | $11.48 | $1.84 |
| Indicator | FSI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 39.48 |
| Support Level | $6.35 | $0.70 |
| Resistance Level | $7.13 | $0.79 |
| Average True Range (ATR) | 0.43 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 32.90 | 11.67 |
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.